nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Hepatic pain—Sorafenib—thyroid cancer	0.117	0.121	CcSEcCtD
Telbivudine—Disease progression—Sorafenib—thyroid cancer	0.0448	0.0461	CcSEcCtD
Telbivudine—Lipase increased—Sorafenib—thyroid cancer	0.0333	0.0343	CcSEcCtD
Telbivudine—Abdominal pain lower—Sorafenib—thyroid cancer	0.0308	0.0317	CcSEcCtD
Telbivudine—Amylase increased—Vandetanib—thyroid cancer	0.0305	0.0314	CcSEcCtD
Telbivudine—Zidovudine—TERT—thyroid cancer	0.0293	1	CrCbGaD
Telbivudine—Amylase increased—Sorafenib—thyroid cancer	0.0205	0.0212	CcSEcCtD
Telbivudine—Lactic acidosis—Epirubicin—thyroid cancer	0.0148	0.0153	CcSEcCtD
Telbivudine—Lactic acidosis—Doxorubicin—thyroid cancer	0.0137	0.0141	CcSEcCtD
Telbivudine—Sepsis—Vandetanib—thyroid cancer	0.0126	0.013	CcSEcCtD
Telbivudine—Rhinorrhoea—Sorafenib—thyroid cancer	0.0121	0.0124	CcSEcCtD
Telbivudine—Multi-organ failure—Epirubicin—thyroid cancer	0.0111	0.0114	CcSEcCtD
Telbivudine—Rhabdomyolysis—Sorafenib—thyroid cancer	0.0111	0.0114	CcSEcCtD
Telbivudine—Multi-organ failure—Doxorubicin—thyroid cancer	0.0103	0.0106	CcSEcCtD
Telbivudine—Influenza like illness—Sorafenib—thyroid cancer	0.0095	0.00978	CcSEcCtD
Telbivudine—Nasopharyngitis—Vandetanib—thyroid cancer	0.00941	0.0097	CcSEcCtD
Telbivudine—Musculoskeletal chest pain—Epirubicin—thyroid cancer	0.00932	0.0096	CcSEcCtD
Telbivudine—Gastritis—Vandetanib—thyroid cancer	0.00931	0.0096	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00928	0.00956	CcSEcCtD
Telbivudine—Influenza—Vandetanib—thyroid cancer	0.0091	0.00937	CcSEcCtD
Telbivudine—Musculoskeletal chest pain—Doxorubicin—thyroid cancer	0.00863	0.00889	CcSEcCtD
Telbivudine—Neutropenia—Vandetanib—thyroid cancer	0.00851	0.00876	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00845	0.00871	CcSEcCtD
Telbivudine—Renal failure—Vandetanib—thyroid cancer	0.00797	0.00821	CcSEcCtD
Telbivudine—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00767	0.0079	CcSEcCtD
Telbivudine—Myositis—Epirubicin—thyroid cancer	0.00737	0.00759	CcSEcCtD
Telbivudine—Pain in extremity—Sorafenib—thyroid cancer	0.0071	0.00731	CcSEcCtD
Telbivudine—Myositis—Doxorubicin—thyroid cancer	0.00682	0.00702	CcSEcCtD
Telbivudine—Mediastinal disorder—Vandetanib—thyroid cancer	0.00656	0.00676	CcSEcCtD
Telbivudine—Abdominal pain upper—Sorafenib—thyroid cancer	0.00648	0.00668	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00639	0.00659	CcSEcCtD
Telbivudine—Nasopharyngitis—Sorafenib—thyroid cancer	0.00635	0.00654	CcSEcCtD
Telbivudine—Malnutrition—Vandetanib—thyroid cancer	0.00634	0.00653	CcSEcCtD
Telbivudine—Gastritis—Sorafenib—thyroid cancer	0.00628	0.00647	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00626	0.00645	CcSEcCtD
Telbivudine—Dysgeusia—Vandetanib—thyroid cancer	0.00621	0.00639	CcSEcCtD
Telbivudine—Muscle spasms—Vandetanib—thyroid cancer	0.00609	0.00628	CcSEcCtD
Telbivudine—Abdominal discomfort—Sorafenib—thyroid cancer	0.00588	0.00606	CcSEcCtD
Telbivudine—Neutropenia—Sorafenib—thyroid cancer	0.00574	0.00591	CcSEcCtD
Telbivudine—Cough—Vandetanib—thyroid cancer	0.00553	0.0057	CcSEcCtD
Telbivudine—Arthralgia—Vandetanib—thyroid cancer	0.0054	0.00556	CcSEcCtD
Telbivudine—Chest pain—Vandetanib—thyroid cancer	0.0054	0.00556	CcSEcCtD
Telbivudine—Renal failure—Sorafenib—thyroid cancer	0.00538	0.00554	CcSEcCtD
Telbivudine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00536	0.00552	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00536	0.00552	CcSEcCtD
Telbivudine—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00517	0.00533	CcSEcCtD
Telbivudine—Hepatomegaly—Epirubicin—thyroid cancer	0.00511	0.00526	CcSEcCtD
Telbivudine—Nervous system disorder—Vandetanib—thyroid cancer	0.00507	0.00523	CcSEcCtD
Telbivudine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00506	0.00522	CcSEcCtD
Telbivudine—Skin disorder—Vandetanib—thyroid cancer	0.00502	0.00518	CcSEcCtD
Telbivudine—Connective tissue disorder—Sorafenib—thyroid cancer	0.00483	0.00497	CcSEcCtD
Telbivudine—Hepatomegaly—Doxorubicin—thyroid cancer	0.00473	0.00487	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00471	0.00485	CcSEcCtD
Telbivudine—Insomnia—Vandetanib—thyroid cancer	0.00468	0.00482	CcSEcCtD
Telbivudine—Paraesthesia—Vandetanib—thyroid cancer	0.00464	0.00478	CcSEcCtD
Telbivudine—Dyspepsia—Vandetanib—thyroid cancer	0.00455	0.00469	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00447	0.0046	CcSEcCtD
Telbivudine—Fatigue—Vandetanib—thyroid cancer	0.00446	0.00459	CcSEcCtD
Telbivudine—Mediastinal disorder—Sorafenib—thyroid cancer	0.00443	0.00456	CcSEcCtD
Telbivudine—Pain—Vandetanib—thyroid cancer	0.00442	0.00456	CcSEcCtD
Telbivudine—Malnutrition—Sorafenib—thyroid cancer	0.00428	0.0044	CcSEcCtD
Telbivudine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00423	0.00436	CcSEcCtD
Telbivudine—Dysgeusia—Sorafenib—thyroid cancer	0.00419	0.00431	CcSEcCtD
Telbivudine—Muscle spasms—Sorafenib—thyroid cancer	0.00411	0.00423	CcSEcCtD
Telbivudine—Body temperature increased—Vandetanib—thyroid cancer	0.00409	0.00421	CcSEcCtD
Telbivudine—Abdominal pain—Vandetanib—thyroid cancer	0.00409	0.00421	CcSEcCtD
Telbivudine—Cough—Sorafenib—thyroid cancer	0.00373	0.00384	CcSEcCtD
Telbivudine—Asthenia—Vandetanib—thyroid cancer	0.00371	0.00382	CcSEcCtD
Telbivudine—Pruritus—Vandetanib—thyroid cancer	0.00366	0.00377	CcSEcCtD
Telbivudine—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00366	0.00377	CcSEcCtD
Telbivudine—Neck pain—Epirubicin—thyroid cancer	0.00366	0.00377	CcSEcCtD
Telbivudine—Arthralgia—Sorafenib—thyroid cancer	0.00364	0.00375	CcSEcCtD
Telbivudine—Myalgia—Sorafenib—thyroid cancer	0.00364	0.00375	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00361	0.00372	CcSEcCtD
Telbivudine—Diarrhoea—Vandetanib—thyroid cancer	0.00354	0.00365	CcSEcCtD
Telbivudine—Influenza like illness—Epirubicin—thyroid cancer	0.00351	0.00362	CcSEcCtD
Telbivudine—Nervous system disorder—Sorafenib—thyroid cancer	0.00342	0.00353	CcSEcCtD
Telbivudine—Dizziness—Vandetanib—thyroid cancer	0.00342	0.00352	CcSEcCtD
Telbivudine—Thrombocytopenia—Sorafenib—thyroid cancer	0.00342	0.00352	CcSEcCtD
Telbivudine—Skin disorder—Sorafenib—thyroid cancer	0.00339	0.00349	CcSEcCtD
Telbivudine—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00339	0.00349	CcSEcCtD
Telbivudine—Neck pain—Doxorubicin—thyroid cancer	0.00339	0.00349	CcSEcCtD
Telbivudine—Vomiting—Vandetanib—thyroid cancer	0.00329	0.00339	CcSEcCtD
Telbivudine—Rash—Vandetanib—thyroid cancer	0.00326	0.00336	CcSEcCtD
Telbivudine—Dermatitis—Vandetanib—thyroid cancer	0.00326	0.00336	CcSEcCtD
Telbivudine—Influenza like illness—Doxorubicin—thyroid cancer	0.00325	0.00335	CcSEcCtD
Telbivudine—Headache—Vandetanib—thyroid cancer	0.00324	0.00334	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00318	0.00327	CcSEcCtD
Telbivudine—Sepsis—Epirubicin—thyroid cancer	0.00314	0.00323	CcSEcCtD
Telbivudine—Nausea—Vandetanib—thyroid cancer	0.00307	0.00317	CcSEcCtD
Telbivudine—Dyspepsia—Sorafenib—thyroid cancer	0.00307	0.00316	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00301	0.0031	CcSEcCtD
Telbivudine—Fatigue—Sorafenib—thyroid cancer	0.00301	0.0031	CcSEcCtD
Telbivudine—Pain—Sorafenib—thyroid cancer	0.00298	0.00307	CcSEcCtD
Telbivudine—Sepsis—Doxorubicin—thyroid cancer	0.0029	0.00299	CcSEcCtD
Telbivudine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00285	0.00294	CcSEcCtD
Telbivudine—Abdominal pain—Sorafenib—thyroid cancer	0.00276	0.00284	CcSEcCtD
Telbivudine—Body temperature increased—Sorafenib—thyroid cancer	0.00276	0.00284	CcSEcCtD
Telbivudine—Renal impairment—Epirubicin—thyroid cancer	0.00276	0.00284	CcSEcCtD
Telbivudine—Pain in extremity—Epirubicin—thyroid cancer	0.00262	0.0027	CcSEcCtD
Telbivudine—Migraine—Epirubicin—thyroid cancer	0.00258	0.00266	CcSEcCtD
Telbivudine—Renal impairment—Doxorubicin—thyroid cancer	0.00255	0.00263	CcSEcCtD
Telbivudine—Asthenia—Sorafenib—thyroid cancer	0.0025	0.00258	CcSEcCtD
Telbivudine—Pruritus—Sorafenib—thyroid cancer	0.00247	0.00254	CcSEcCtD
Telbivudine—Pain in extremity—Doxorubicin—thyroid cancer	0.00243	0.0025	CcSEcCtD
Telbivudine—Abdominal pain upper—Epirubicin—thyroid cancer	0.0024	0.00247	CcSEcCtD
Telbivudine—Migraine—Doxorubicin—thyroid cancer	0.00239	0.00246	CcSEcCtD
Telbivudine—Diarrhoea—Sorafenib—thyroid cancer	0.00239	0.00246	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00236	0.00243	CcSEcCtD
Telbivudine—Nasopharyngitis—Epirubicin—thyroid cancer	0.00235	0.00242	CcSEcCtD
Telbivudine—Gastritis—Epirubicin—thyroid cancer	0.00232	0.00239	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00231	0.00238	CcSEcCtD
Telbivudine—Muscular weakness—Epirubicin—thyroid cancer	0.00231	0.00238	CcSEcCtD
Telbivudine—Dizziness—Sorafenib—thyroid cancer	0.00231	0.00238	CcSEcCtD
Telbivudine—Abdominal distension—Epirubicin—thyroid cancer	0.00228	0.00235	CcSEcCtD
Telbivudine—Influenza—Epirubicin—thyroid cancer	0.00227	0.00234	CcSEcCtD
Telbivudine—Vomiting—Sorafenib—thyroid cancer	0.00222	0.00229	CcSEcCtD
Telbivudine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00222	0.00228	CcSEcCtD
Telbivudine—Rash—Sorafenib—thyroid cancer	0.0022	0.00227	CcSEcCtD
Telbivudine—Dermatitis—Sorafenib—thyroid cancer	0.0022	0.00226	CcSEcCtD
Telbivudine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00219	0.00225	CcSEcCtD
Telbivudine—Headache—Sorafenib—thyroid cancer	0.00219	0.00225	CcSEcCtD
Telbivudine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00217	0.00224	CcSEcCtD
Telbivudine—Gastritis—Doxorubicin—thyroid cancer	0.00215	0.00221	CcSEcCtD
Telbivudine—Muscular weakness—Doxorubicin—thyroid cancer	0.00214	0.00221	CcSEcCtD
Telbivudine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00214	0.00221	CcSEcCtD
Telbivudine—Neutropenia—Epirubicin—thyroid cancer	0.00212	0.00218	CcSEcCtD
Telbivudine—Abdominal distension—Doxorubicin—thyroid cancer	0.00211	0.00218	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00211	0.00217	CcSEcCtD
Telbivudine—Influenza—Doxorubicin—thyroid cancer	0.0021	0.00216	CcSEcCtD
Telbivudine—Nausea—Sorafenib—thyroid cancer	0.00207	0.00214	CcSEcCtD
Telbivudine—Renal failure—Epirubicin—thyroid cancer	0.00199	0.00205	CcSEcCtD
Telbivudine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00198	0.00204	CcSEcCtD
Telbivudine—Neutropenia—Doxorubicin—thyroid cancer	0.00196	0.00202	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00195	0.00201	CcSEcCtD
Telbivudine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00191	0.00197	CcSEcCtD
Telbivudine—Renal failure—Doxorubicin—thyroid cancer	0.00184	0.00189	CcSEcCtD
Telbivudine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00183	0.00189	CcSEcCtD
Telbivudine—Hepatitis—Epirubicin—thyroid cancer	0.00182	0.00187	CcSEcCtD
Telbivudine—Hypoaesthesia—Epirubicin—thyroid cancer	0.00181	0.00186	CcSEcCtD
Telbivudine—Pharyngitis—Epirubicin—thyroid cancer	0.0018	0.00186	CcSEcCtD
Telbivudine—Connective tissue disorder—Epirubicin—thyroid cancer	0.00178	0.00184	CcSEcCtD
Telbivudine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00177	0.00182	CcSEcCtD
Telbivudine—Hepatitis—Doxorubicin—thyroid cancer	0.00168	0.00173	CcSEcCtD
Telbivudine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00167	0.00172	CcSEcCtD
Telbivudine—Pharyngitis—Doxorubicin—thyroid cancer	0.00167	0.00172	CcSEcCtD
Telbivudine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00165	0.0017	CcSEcCtD
Telbivudine—Mediastinal disorder—Epirubicin—thyroid cancer	0.00164	0.00169	CcSEcCtD
Telbivudine—Malnutrition—Epirubicin—thyroid cancer	0.00158	0.00163	CcSEcCtD
Telbivudine—Dysgeusia—Epirubicin—thyroid cancer	0.00155	0.00159	CcSEcCtD
Telbivudine—Back pain—Epirubicin—thyroid cancer	0.00153	0.00157	CcSEcCtD
Telbivudine—Muscle spasms—Epirubicin—thyroid cancer	0.00152	0.00156	CcSEcCtD
Telbivudine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00151	0.00156	CcSEcCtD
Telbivudine—Ill-defined disorder—Epirubicin—thyroid cancer	0.00147	0.00151	CcSEcCtD
Telbivudine—Malnutrition—Doxorubicin—thyroid cancer	0.00146	0.00151	CcSEcCtD
Telbivudine—Dysgeusia—Doxorubicin—thyroid cancer	0.00143	0.00147	CcSEcCtD
Telbivudine—Malaise—Epirubicin—thyroid cancer	0.00142	0.00147	CcSEcCtD
Telbivudine—Back pain—Doxorubicin—thyroid cancer	0.00141	0.00146	CcSEcCtD
Telbivudine—Muscle spasms—Doxorubicin—thyroid cancer	0.00141	0.00145	CcSEcCtD
Telbivudine—Cough—Epirubicin—thyroid cancer	0.00138	0.00142	CcSEcCtD
Telbivudine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00136	0.0014	CcSEcCtD
Telbivudine—Chest pain—Epirubicin—thyroid cancer	0.00135	0.00139	CcSEcCtD
Telbivudine—Myalgia—Epirubicin—thyroid cancer	0.00135	0.00139	CcSEcCtD
Telbivudine—Arthralgia—Epirubicin—thyroid cancer	0.00135	0.00139	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00134	0.00138	CcSEcCtD
Telbivudine—Discomfort—Epirubicin—thyroid cancer	0.00133	0.00137	CcSEcCtD
Telbivudine—Malaise—Doxorubicin—thyroid cancer	0.00132	0.00136	CcSEcCtD
Telbivudine—Cough—Doxorubicin—thyroid cancer	0.00128	0.00131	CcSEcCtD
Telbivudine—Nervous system disorder—Epirubicin—thyroid cancer	0.00126	0.0013	CcSEcCtD
Telbivudine—Thrombocytopenia—Epirubicin—thyroid cancer	0.00126	0.0013	CcSEcCtD
Telbivudine—Skin disorder—Epirubicin—thyroid cancer	0.00125	0.00129	CcSEcCtD
Telbivudine—Myalgia—Doxorubicin—thyroid cancer	0.00124	0.00128	CcSEcCtD
Telbivudine—Chest pain—Doxorubicin—thyroid cancer	0.00124	0.00128	CcSEcCtD
Telbivudine—Arthralgia—Doxorubicin—thyroid cancer	0.00124	0.00128	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00124	0.00127	CcSEcCtD
Telbivudine—Discomfort—Doxorubicin—thyroid cancer	0.00123	0.00127	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00117	0.00121	CcSEcCtD
Telbivudine—Nervous system disorder—Doxorubicin—thyroid cancer	0.00117	0.00121	CcSEcCtD
Telbivudine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00117	0.0012	CcSEcCtD
Telbivudine—Insomnia—Epirubicin—thyroid cancer	0.00117	0.0012	CcSEcCtD
Telbivudine—Skin disorder—Doxorubicin—thyroid cancer	0.00116	0.00119	CcSEcCtD
Telbivudine—Paraesthesia—Epirubicin—thyroid cancer	0.00116	0.00119	CcSEcCtD
Telbivudine—Dyspepsia—Epirubicin—thyroid cancer	0.00114	0.00117	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00111	0.00115	CcSEcCtD
Telbivudine—Fatigue—Epirubicin—thyroid cancer	0.00111	0.00115	CcSEcCtD
Telbivudine—Pain—Epirubicin—thyroid cancer	0.0011	0.00114	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00109	0.00112	CcSEcCtD
Telbivudine—Insomnia—Doxorubicin—thyroid cancer	0.00108	0.00111	CcSEcCtD
Telbivudine—Paraesthesia—Doxorubicin—thyroid cancer	0.00107	0.0011	CcSEcCtD
Telbivudine—Feeling abnormal—Epirubicin—thyroid cancer	0.00106	0.00109	CcSEcCtD
Telbivudine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00105	0.00109	CcSEcCtD
Telbivudine—Dyspepsia—Doxorubicin—thyroid cancer	0.00105	0.00108	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00103	0.00106	CcSEcCtD
Telbivudine—Fatigue—Doxorubicin—thyroid cancer	0.00103	0.00106	CcSEcCtD
Telbivudine—Pain—Doxorubicin—thyroid cancer	0.00102	0.00105	CcSEcCtD
Telbivudine—Body temperature increased—Epirubicin—thyroid cancer	0.00102	0.00105	CcSEcCtD
Telbivudine—Abdominal pain—Epirubicin—thyroid cancer	0.00102	0.00105	CcSEcCtD
Telbivudine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000983	0.00101	CcSEcCtD
Telbivudine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000976	0.00101	CcSEcCtD
Telbivudine—Abdominal pain—Doxorubicin—thyroid cancer	0.000943	0.000972	CcSEcCtD
Telbivudine—Body temperature increased—Doxorubicin—thyroid cancer	0.000943	0.000972	CcSEcCtD
Telbivudine—Asthenia—Epirubicin—thyroid cancer	0.000925	0.000953	CcSEcCtD
Telbivudine—Pruritus—Epirubicin—thyroid cancer	0.000912	0.00094	CcSEcCtD
Telbivudine—Diarrhoea—Epirubicin—thyroid cancer	0.000882	0.000909	CcSEcCtD
Telbivudine—Asthenia—Doxorubicin—thyroid cancer	0.000856	0.000882	CcSEcCtD
Telbivudine—Dizziness—Epirubicin—thyroid cancer	0.000853	0.000878	CcSEcCtD
Telbivudine—Pruritus—Doxorubicin—thyroid cancer	0.000844	0.00087	CcSEcCtD
Telbivudine—Vomiting—Epirubicin—thyroid cancer	0.00082	0.000845	CcSEcCtD
Telbivudine—Diarrhoea—Doxorubicin—thyroid cancer	0.000816	0.000841	CcSEcCtD
Telbivudine—Rash—Epirubicin—thyroid cancer	0.000813	0.000838	CcSEcCtD
Telbivudine—Dermatitis—Epirubicin—thyroid cancer	0.000812	0.000837	CcSEcCtD
Telbivudine—Headache—Epirubicin—thyroid cancer	0.000808	0.000832	CcSEcCtD
Telbivudine—Dizziness—Doxorubicin—thyroid cancer	0.000789	0.000813	CcSEcCtD
Telbivudine—Nausea—Epirubicin—thyroid cancer	0.000766	0.000789	CcSEcCtD
Telbivudine—Vomiting—Doxorubicin—thyroid cancer	0.000759	0.000782	CcSEcCtD
Telbivudine—Rash—Doxorubicin—thyroid cancer	0.000752	0.000775	CcSEcCtD
Telbivudine—Dermatitis—Doxorubicin—thyroid cancer	0.000752	0.000774	CcSEcCtD
Telbivudine—Headache—Doxorubicin—thyroid cancer	0.000748	0.00077	CcSEcCtD
Telbivudine—Nausea—Doxorubicin—thyroid cancer	0.000709	0.00073	CcSEcCtD
